Alterations in p53 are the most common mutations in gliomas of astrocytic lineage, found in 50% of grade II (diffuse astrocytoma) and III (anaplastic astrocytoma) gliomas, in 25–30% of primary GBM, and in 60–70% of secondary GBM [127,128]. Here, TP53 is linked to central nervous system cancer.